CanSino Biologics, Inc. Class H's total assets for Q3 2025 were ¥7.30B, a decrease of -5.24% from the previous quarter. HK:6185 total liabilities were ¥2.37B for the fiscal quarter, a -15.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.